Varsha Gandhi

University Of Tx Md Anderson Can Ctr

$2,500,715

Attributed

$2,500,715

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $279.3K · FY2005–24

$500K$375K$250K$125K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

Funding mix

By agency

NIH$2,100,715 · 4

FDA$400,000 · 1

By mechanism

R01$1,880,931 · 2

R21$405,184 · 1

P50$204,600 · 1

R13$10,000 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Tx Md Anderson Can Ctr

Same institution · by research overlap

George A. Calin$5,774,539
Anil K Sood$29,572,737
Michael W Andreeff$17,991,896
Moran Amit$4,840,424
Scott Kopetz$13,199,822

Others in their field

Top investigators on “Nucleoside Analog”

Constance Ann Benson · University Of California, San Diego$84,289,569
Robert Turner Schooley · University Of Colorado Denver$49,550,018
Jeffrey S Glenn · Stanford University$19,514,752
Ruth Martha Greenblatt · University Of California San Francisco$19,382,210
Vern L. Schramm · Yeshiva University$18,631,228
Xuping Xie · University Of Texas Med Br Galveston$13,737,799

Research focus

Nucleoside AnalogApoptosisNeoplastic CellFludarabineDna RepairPharmaceutical PreparationsBiologyAcute Myelogenous LeukemiaDrug Screening /EvaluationOxidative PhosphorylationDna ReplicationDisease RemissionAntileukemic AgentDesignDoseDrug MetabolismCyclophosphamideClinical ResearchClinical ProtocolsClinical TrialsCombined Modality TherapyCombination Cancer TherapyCytotoxicityDrug Interactions